by Sevanny Campos | Dec 22, 2020 | AbbVie, Companies
AbbVie’s 2020 acquisition Allergan is helping diversify the company’s revenue but its latest earnings report shows it still has a long way to go before matching the sales brought in by its leading product. AbbVie Inc exceeded earnings expectations for sales...
by Sevanny Campos | Dec 21, 2020 | AbbVie, Companies
Abbvie Inc was one of the three companies chosen for trials of Covid-19 treatment. The company submitted a drug acquired from the Allergan Inc. acquisition. Johnson & Johnson and Gilead were also chosen for the trial. The National Institutes of Health...
by Minji Koo | Dec 17, 2020 | Corporate Strategy, Lululemon, News
Anne Howard, a mother of two teenage daughters in San Francisco, said she was a loyal Lululemon customer and enjoyed shopping at a store near her home. But when she bought a gift for her husband this holiday, she chose Nike jerseys because the No. 1 pick for her...
by Colin Kern | Dec 17, 2020 | Netflix
With its streaming service approaching saturation in the United States, Netflix is bringing the playbook that up-ended Hollywood to Bollywood, where India offers its most promising opportunity. To claim a market-share lead in India, Netflix is taking the playbook it...
by Sonya Swink | Dec 17, 2020 | Companies, Corporate Strategy, News, Retail, Yeti
Yeti topped the charts in 2020, hitting record sales as it benefited from a limited economy due to Covid-19 shutdowns. Still, Yeti (NYSE: YETI) has not set out a plan to stay on top amidst a vaccinated world and growing competition. When bars, theaters and...
by Minji Koo | Dec 17, 2020 | Earnings, Lululemon
Lululemon on Dec.10 reported $1.1 billion in sales in its third quarter, which ended Nov.1. With sales up 22% from the same period the year before, the company again beat analysts’ estimates — no surprise, given soaring demand for comfortable clothes and the huge...